Picture of Fresh Tracks Therapeutics logo

FRTX — Fresh Tracks Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapTurnaround

Brief: Fresh Tracks Therapeutics Appoints Andrew Sklawer As Chief Executive Officer

Jan 27 (Reuters) - Fresh Tracks Therapeutics Inc
 FRTX.O :
    * FRESH TRACKS THERAPEUTICS APPOINTS ANDREW SKLAWER AS CHIEF
EXECUTIVE OFFICER
    * FRESH TRACKS THERAPEUTICS INC - SKLAWER WILL SUCCEED ROB
BROWN,
WHO HAS LED COMPANY AS CEO SINCE 2019 AND IS RETIRING
    * FRESH TRACKS THERAPEUTICS INC - BROWN WILL CONTINUE TO
SERVE AS
A NON-EXECUTIVE MEMBER OF BOARD OF DIRECTORS AND A SPECIAL
ADVISOR TO CO
    * FRESH TRACKS THERAPEUTICS INC - BOARD HAS APPOINTED ANDREW
SKLAWER, CO'S CURRENT PRESIDENT, AS CEO, EFFECTIVE FEBRUARY 1,
2023

Source text for Eikon:  ID:nGNX395YRG 
Further company coverage:  FRTX.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Fresh Tracks Therapeutics

See all news